Journal of Clinical Medicine (Jun 2023)
Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. <i>J. Clin. Med.</i> 2022, <i>11</i>, 6189
- Pavel Jansa,
- David Ambrož,
- Michael Aschermann,
- Vladimír Černý,
- Vladimír Dytrych,
- Samuel Heller,
- Jan Kunstýř,
- Jaroslav Lindner,
- Aleš Linhart,
- Matúš Nižnanský,
- Michal Pad’our,
- Tomáš Prskavec,
- Michal Širanec,
- Susan Edwards,
- Virginie Gressin,
- Matyáš Kuhn,
- Lilla Di Scala
Affiliations
- Pavel Jansa
- 2nd Department of Internal Medicine–Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- David Ambrož
- 2nd Department of Internal Medicine–Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Michael Aschermann
- 2nd Department of Internal Medicine–Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Vladimír Černý
- Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Vladimír Dytrych
- 2nd Department of Internal Medicine–Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Samuel Heller
- 2nd Department of Internal Medicine–Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Jan Kunstýř
- Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Jaroslav Lindner
- 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Aleš Linhart
- 2nd Department of Internal Medicine–Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Matúš Nižnanský
- 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Michal Pad’our
- 2nd Department of Internal Medicine–Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Tomáš Prskavec
- 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Michal Širanec
- 2nd Department of Internal Medicine–Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
- Susan Edwards
- Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland
- Virginie Gressin
- Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland
- Matyáš Kuhn
- Data Analysis Department, Institute of Biostatistics and Analysis Ltd., 602 00 Brno, Czech Republic
- Lilla Di Scala
- Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland
- DOI
- https://doi.org/10.3390/jcm12123939
- Journal volume & issue
-
Vol. 12,
no. 12
p. 3939
Abstract
Error in Figure [...]
Keywords
